| [1] |
谢幸, 苟文丽. 妇产科学[M]. 北京: 人民卫生出版社, 2016.
|
| [2] |
Kiefel H, Bondong S, Hazin J, et al. L1CAM A major driver for tumor cell invasion and motility [J]. Cell Adh Migr, 2012, 6(4): 374-384.
|
| [3] |
Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers [J]. Cell Biol, 2015, 168(4): 633-642.
|
| [4] |
Huszar M, Pfeifer M, Schirmer U, et al. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas [J]. J Pathol, 2010, 220(5): 551-561.
|
| [5] |
Altevogt P, Doberstein K, Fogel M, et al. L1CAM in human cancer [J]. Int J Cancer, 2016, 138(7): 1565-1576.
|
| [6] |
Zecchini S, Bianchi M, Colombo N, et al. The differential role of l1 in ovarian carcinoma and normal ovarian surface epithelium [J]. Cancer Res, 2008, 68(4): 1110-1118
|
| [7] |
Stoeck A, Keller S, Riedle S, et al. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44 [J]. Biochem J, 2006, 393(3): 609-618.
|
| [8] |
Colas E, Pedrola N, Devis L, et al. The EMT signaling pathways in endometrial carcinoma [J]. Clin Transl Oncol, 2012, 14(10): 715-720.
|
| [9] |
Shtutman M, Levina E, Ohouo P, et al. Celladhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells [J]. Cancer Res, 2006, 66(23): 11370-11380.
|
| [10] |
Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers [J]. J Cell Biol, 2005, 168(4): 633-642.
|
| [11] |
Silletti S, Yebra M, Perez B, et al. Extracellular signal-regulated kinase(ERK)-dependent gene expression contributes to L1 Cell adhesion molecule-dependent motility and invasion [J]. J Biol Chem, 2004, 24(28): 28880-28888.
|
| [12] |
卞奕丁，万小平. Wnt信号通路与子宫内膜癌研究进展 [J]. 现代妇产科进展, 2015, 24(11): 867-869.
|
| [13] |
Schaefer AW, Kamiguchi H, Wong EV, et al. Activation of the MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization [J]. J Biol Chem, 1999, 274(53): 37965-37973.
|
| [14] |
Batlle E, Bacani J, Begthel H, et al. Eph B/Ephrin B receptors and Wnt signaling incolorectal cancer [J]. Cancer Res, 2006, (66): 2-5.
|
| [15] |
Connacci-Sorell M, Zhurinski J, Ben-Ze′ev A. The cadherin-catenin adhesion system in signaling and cancer [J]. J Clin Invest, 2002, 109(8): 987-991.
|
| [16] |
Meier F, Busch S, Gast D, et al. The adhesion molecule L1(CD171) promotes melanoma progression [J]. Int J Cancer, 2006, 119(3): 549-555.
|
| [17] |
Gutwein P, Stoeck A, Riedle S, et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells [J]. Clin. Cancer Res, 2005, 11(7): 2492-2501.
|
| [18] |
Fogel M, Gutwein P, Mechtersheimer S, et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas [J].. Lancet, 2003, 362(9387): 869-875.
|
| [19] |
Dellinger TH, Smith DD, Ouyang C, et al. L1CAM is an independent predictor of poor survival in endometrialcancer - An analysis of The Cancer Genome Atlas(TCGA) [J]. Gynecologic Oncol, 2016, 141(2): 336-340.
|
| [20] |
Zeimet AG, Reimer D, Huszar M, et al. L1CAM in early-Stage type I endometrial cancer: results of a large Multicenter evaluation [J]. J Natl Cancer Inst, 2013, 105(15): 1142-1150.
|
| [21] |
Stelloo E, Nout RA, Osse EM, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC Cohorts [J]. Clin Cancer Res, 2016, 22(16): 4215-4224.
|
| [22] |
Suh DH, Kim MA, Kim HS, et al. L1 cell adhesion molecule expression is associated with pelvic lymph node metastasis and advanced stage in diabetic patients with endometrial cancer: a matched case control study [J]. Cancer Prev, 2014, 19(3): 231-239.
|
| [23] |
Geels YP, Pijnenborg JM, Gorden BB, et al. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma [J]. Pathol, Oncol Res, 2016, 22(4): 863-868.
|
| [24] |
Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition incancer: parallels between normal development and tumor progression [J]. Mammary Gland Biol Neoplasia, 2010, 15(2): 117-134.
|
| [25] |
Abdel Azim S, Sprung S, Mutz-Dehbalaie I, et al. L1CAM and HER2 expression in early endometrioid uterine cancer [J]. Int J Gynecol Pathol, 2017, 36(4): 356-363.
|